CVE-2026-29097 json
SuiteCRM Server-Side Request Forgery and Denial of Service via RSS Feed Dashlet
published 2026-03-19 7 mo ago modified 2026-06-17 4 mo ago also EUVD-2026-13353
- cvss
- 7.5
- version 3.1, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 24%
- public exploits
- 0
- none known
Summary
SuiteCRM is an open-source, enterprise-ready Customer Relationship Management (CRM) software application. Versions prior to 7.15.1 and 8.9.3 contain a Server-Side Request Forgery (SSRF) vulnerability combined with a Denial of Service (DoS) condition in the RSS Feed Dashlet component. Versions 7.15.1 and 8.9.3 patch the issue.
Patch / fix
- suitecrm suitecrm 7.15.1, 8.9.3
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- 7 mo ago
Exploit prediction
0.31% chance of exploitation in the next 30 days, higher than 24% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 4.0 | 7.1 | CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:H/SC:L/SI:N/SA:N |
| CNA | 4.0 | 7.1 | CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:H/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X |
| NVD | 3.1 | 7.5 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H |
Affected products
- SuiteCRM SuiteCRM
Classification
- Weakness
-
- CWE-918 Server-Side Request Forgery
References
-
github.com
/SuiteCRM/SuiteCRM/security/advisories/GHSA-x3p2-qcqh-qx2m
vendor-advisory
-
docs.suitecrm.com
/admin/releases/7.15.x
release-notes
Sources
- CVE List CVE-2026-29097
- NVD CVE-2026-29097
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.